News & Analysis on Clinical Trial Services & Contract Research And Development
UK-based vaccine maker PowderJect is now said to be in the latter stages of takeover negotiations, with the interested party widely tipped to be the USA's Chiron, rumoured to be proferring a bid valuing the company at around £500 million (€698 million).
In the US this week, supplier of botanical extracts for the pharmaceutical industry Pharmachem Laboratories announced that it has acquired 'the largest botanical extraction facility in North America, producing extracts for the fragrance,...
Three major players will try to recover costs from Pan Pharmaceuticals after Australia's largest ever medical products recall, reports IndustrySearch.com.
Dutch life sciences company DSM has broken ground on a new site in Montreal, Canada, set to become a large-scale biopharmaceuticals plant. Phase one - at a cost of €100m - due for completion by 2005.